Molecular Templates

MTEM63

High Value

$0.46arrow_drop_down23.99%-$0.14

High Value

Penny Stock

MTEM63

$0.46

arrow_drop_down23.99%-$0.14

High Value

Penny Stock

Performance History

Key Stats
Open	$0.53
Prev. Close	$0.61
EPS	-3.05
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$3.07M
PE Ratio	-

	LOW	HIGH
Day Range	0.40	0.72
52 Week Range	0.32	6.93

Ratios

Revenue	-





EPS	-3.05

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Molecular Templates (MTEM)

The stock price history of Molecular Templates Inc (MTEM) shows significant fluctuations over the years. The company went public in 2013 with an initial offering price of $6 per share. Since then, the stock has experienced both ups and downs, reaching a high of $14.50 in 2015 and a low of $1.20 in 2018. As of the most recent closing price, MTEM is trading at $7.60. The stock has shown some volatility in recent months, but overall, it has maintained a relatively stable price.

Molecular Templates Inc (MTEM) is a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immunotoxins called Engineered Toxin Bodies (ETBs). These ETBs have the potential to target and destroy specific cells, making them promising candidates for the treatment of various cancers and other diseases. The company has several ongoing clinical trials, including studies investigating the use of ETBs in multiple myeloma, non-Hodgkin lymphoma, and ovarian cancer.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Eric E. Poma Ph.D.
Headquarters: Austin
Employees: 111
Exchange: NASDAQ

Keep an eye on Molecular Templates

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Molecular Templates 's (MTEM) price per share?

The current price per share for Molecular Templates (MTEM) is $0.47. The stock has seen a price change of -$0.15 recently, indicating a -24% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Molecular Templates (MTEM)?

For Molecular Templates (MTEM), the 52-week high is $6.93, which is 1.38K% from the current price. The 52-week low is $0.32, the current price is 45.55% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Molecular Templates (MTEM) a growth stock?

Molecular Templates (MTEM) has shown an average price growth of -6.65% over the past three years. It has received a score of 96 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Molecular Templates as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Molecular Templates (MTEM) stock price performance year to date (YTD)?

As of the latest data, Molecular Templates (MTEM) has a year-to-date price change of -87.42%. Over the past month, the stock has experienced a price change of 43.71%. Over the last three months, the change has been -68.43%. Over the past six months, the figure is -68.85%. Looking at a longer horizon, the five-year price change stands at -99.57%.

help

Is Molecular Templates (MTEM) a profitable company?

Molecular Templates (MTEM) has a net income of -$8.12M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 87.94% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.45K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $50.4M. Operating income is noted at -$10.47M. Furthermore, the EBITDA is -$13.86M.

help

What is the market capitalization of Molecular Templates (MTEM)?

Molecular Templates (MTEM) has a market capitalization of $3.08M. The average daily trading volume is 0.52, indicating the stock's liquidity and investor engagement.

News

HEALTH

Jun 3, 2024

Molecular Templates, Inc. Provides Interim Update

EARNINGS RELEASES AND OPERATING RESULTS

May 15, 2024

Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update

CALENDAR OF EVENTS

Apr 9, 2024

Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism

EARNINGS RELEASES AND OPERATING RESULTS

Mar 29, 2024

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

FINANCING AGREEMENTS

Mar 28, 2024

Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement